Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab home-use administration study
NCT01879319Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2013
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of evolocumab in hypercholesterolemia, mixed dyslipidemia, sponsored by Amgen. Started Jul 2013; status: completed.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT01879319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01879319.